Influenza vaccine market dynamics-Reference-Cited by-同舟云学术

Influenza vaccine market dynamics

Published:2009-11 Issue:11 Volume:8 Page:841-842
ISSN:1474-1776
Container-title:Nature Reviews Drug Discovery
language:en
Short-container-title:Nat Rev Drug Discov

Author:

Kresse Hedwig,Rovini Holger

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.nature.com/articles/nrd3026.pdf

Reference8 articles.

1. Datamonitor Commercial Insight: Influenza Vaccines and Antivirals – The pandemic's long-term impact (2009).

2. Center for Disease Control and Prevention. Projected influenza vaccination target population sizes, vaccination coverage and doses to be used during the 2008–09 season. The Center for Disease Control and Prevention website [online] (2008).

3. Center for Disease Control and Prevention. Vaccine Price List. The Center for Disease Control and Prevention website [online] (2009).

4. Sanofi Aventis 2008 Annual Report.

5. Danzon, P. M., Pereira, N. S. & Tejwani, S. S. Vaccine supply: a cross national perspective. Available from http://medicine.uchicago.edu/centers/ccme/Vaccines/danzon.ppt (2005).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An opportunity to incentivize innovation to increase vaccine safety in the United States by improving vaccine delivery using vaccine patches;Vaccine;2020-05

2. Cerium dioxide nanoparticles increase immunogenicity of the influenza vaccine;Antiviral Research;2016-03

3. Flucelvax (Optaflu) for seasonal influenza;Expert Review of Vaccines;2015-05-12

4. Preventable Disease Practices Among a Lower SES, Multicultural, Nonurban, U.S. Community: The Roles of Vaccination Efficacy and Personal Constraints;Health Communication;2013-11-22

5. Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans;Clinical Infectious Diseases;2012-03-22